NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/04/2022
Back to search
Official data from USPTO
GLYCOSTEM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
10/04/2022
Trademark type
Combined
Nice classes
5, 35, 42, 44
Filing date
02/09/2021
Registration date
10/04/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/04/2022
Last transaction
10/04/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
3
Owner type
99
Owner location
Oss, NL
Examiner
CORNWELL, ANDREA B
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the dark blue stylized wording "GLYCOSTEM" to the left of an abstraction of a dark blue cell with a light blue nucleus inside, shaped like a light blue oval and dark blue crescent.
Holders and representatives
Holders
Glycostem Therapeutics B.V.
Representatives
Cynthia R. Adwere LAW OFFICE OF CYNTHIA R. ADWERE
Technical classification
Nice Classes
Class 5Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Cells for medical use
Class 35
Business and administrative servicesbusiness administration servicesbusiness consultancy; Compiling statistics relating to clinical and medical trialsstudies; Collecting and managing medical data in a database in the field of medical studies; Informationconsultancy and advice relating to the aforesaid serviceswhether or not via the Internet
Class 42
Science and technology servicesscientific researchanalysistesting in the field of cellular immunotherapy; medical research servicesincluding clinical studieshealthcare research and blood testing serviceshealth research services and stem cell research; Industrial analysis and research services in the field of cells for medical use; Scientific study and research in the field of medicinepreparing conductingassessingresearching and reporting on scientific studies for medical purposes and clinical research and bioscience studies for industrial purposes; Medical laboratory servicesBacteriology laboratoriesChemical laboratories; Automation services in the field of medical and industrial researchnamely creation of control programs for automation in the field of medical and industrial researchfor automated measurementassemblyadjustmentrelated visualization; cell culture services for medical research purposesfor others; Clinical research services in the field of cellular immunotherapy; informationadvice and consultancy relating to the aforesaid serviceswhether or not via the Internet
Class 44
Medical services; informationconsultancy and advice on the aforesaid serviceswhether or not via the Internet
Publications
History of USPTO decisions and trademark events.
26 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/04/2022
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
08/31/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/31/2022
IUCN
NOTICE OF ALLOWANCE CANCELLED
08/25/2022
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
08/25/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/01/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/04/2022
PUBO
PUBLISHED FOR OPPOSITION
01/04/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/15/2021
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
12/01/2021
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
11/26/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/23/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/29/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/28/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/28/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/20/2021
GNRT
NON-FINAL ACTION E-MAILED
05/20/2021
CNRT
NON-FINAL ACTION WRITTEN
05/20/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/19/2021
GNRT
NON-FINAL ACTION E-MAILED
05/19/2021
CNRT
NON-FINAL ACTION WRITTEN
05/19/2021
DOCK
ASSIGNED TO EXAMINER
05/18/2021
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
05/15/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/14/2021
NWAP
NEW APPLICATION ENTERED
02/12/2021
Continuous trademark protection
Get notified about every new filing that threatens GLYCOSTEM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.